Clinical Trial Update: A Study of MHB046C Injection in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for MHB046C Injection in patients with advanced solid tumors, currently recruiting for Phase 1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• MHB046C Injection (MHB046C)

Snippet

Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd | Conditions: Advanced Solid Cancer | Phase 1, Phase 2 | Status: RECRUITING